Search results
Results from the WOW.Com Content Network
Feb. 12—Do you keep Narcan in your purse? If not, maybe you should. Narcan, known generically as Naloxone, is an overdose reversal drug that's risen in use as the opioid epidemic has continued ...
NEXT (Needle EXchange Technology) Harm Reduction is an American nonprofit that sends naloxone, sterile syringes, and other harm reduction supplies through the mail. [1] It is based in the state of New York but serves clients throughout the country. [1] It is the first formal mail-delivered harm reduction service in the US. [2]
Maya Doe-Simkins, co-director of Remedy Alliance/For The People, which launched last year to provide low-cost or free naloxone to community-based, harm-reduction programs, said governments should ...
REACH acquired funding from the New York City Department of Health and Mental Hygiene for the creation of overdose education and naloxone distribution. [31] As a result, 4,235 naloxone kits were distributed to 3,906 individuals and REACH conducted both bystander training and clinic staff training.
Naloxone is a non-selective and competitive opioid receptor antagonist. [6] [17] It reverses the depression of the central nervous system and respiratory system caused by opioids. [13] Naloxone was patented in 1961 and approved for opioid overdose in the United States in 1971. [18] [19] It is on the World Health Organization's List of Essential ...
For premium support please call: 800-290-4726 more ways to reach us
Naloxone rapidly reverses or blocks the effects of opioids, restoring normal respiration, especially when given within minutes of the first signs of an overdose. Walgreens launches own brand of ...
Tonix is currently developing an extended-release form of TNX-601 ER (tianeptine oxalate extended-release tablets), a naloxone-free formulation of TNX-601, to treat major depressive disorder. [80] In October 2022, Tonix announced that the U.S. Food and Drug Administration (FDA) cleared the Investigational New Drug (IND) application for TNX-601 ...